NF-κB in Squamous Cell Carcinoma
In the article on NF-κB in squamous cell carcinoma in the September 15, 2004 issue of Cancer Research (1), the entries in Tables 1 and 2 indicating NF-κB modulated genes should have been boldfaced. The corrected Tables 1 and 2 are reproduced below.
1. Loercher A, Lee TL, Ricker JL, Howard A, Geoghegen J, Chen Z, Sunwoo JB, Sitcheran R, Chuang EY, Mitchell JB, Baldwin AS Jr, Van Waes C: Nuclear factor-κB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma. Cancer Res 2004;64:6511–23
Selected list of genes increased with tumor progression
Function Gene . | Symbol . | Clone ID . | NF-κB Association . | Fold change . | . | |
---|---|---|---|---|---|---|
. | . | . | . | LY-2/Ker . | LY-2/IkB-aM . | |
Cell cycle/growth | ||||||
Cyclin D1* | Ccnd1 | H3084D05 | Target gene | 3.351 | −2.266 | |
Cyclin D2* | Ccnd2 | H3152D01 | Target gene | 2.957 | −2.05 | |
Growth arrest specific 5* | Gas5 | H3113A12 | 6.304 | −7.813 | ||
Milk fat globule-EGF factor 8* | Mfge8 | H3126F11 | Target gene | 2.594 | −3.525 | |
Protein phosphatase 3*† | Ppp3cb | H3065C08 | Inhibitor of NF-κB | 3.117 | −2.231 | |
Proliferating cell nuclear antigen* | Pcna | H3021F12 | Target gene | 5.775 | −2.811 | |
Apoptosis | ||||||
Baculoviral IAP repeat* | Birc2 | H3074A02 | Target gene | 9.154 | −6.013 | |
Bcl-2 related ovarian killer*† | Bok1 | H3081D02 | 1.994 | −3.461 | ||
Immediate early response 3* | Ier3 | H3057B07 | Target gene | 2.865 | −3.851 | |
Transformation related protein*† | Trp53 | H3142D07 | Target gene | 2.9 | −4.142 | |
Uchrp* | Uchrp | IMAGE:605056 | 2.188 | −4.353 | ||
Inflammation/angiogenesis | ||||||
Colony stimulating factor 1* | Csf1 | H3057D05 | Target gene | 14.639 | −5.574 | |
Complement component 3*† | C3 | H3054A08 | Target gene | 5.145 | −8.303 | |
FGF receptor* | Fgfr4 | IMAGE:406823 | Target gene | 1.982 | −1.991 | |
Gro 1 oncogene* | Gro1 | H3051F10 | Target gene | 12.394 | −4.094 | |
Histocompatibility 2-L* | H2-L | H3096A12 | Target gene | 2.342 | −3.431 | |
Histocompatibility 2-D* | H2-D | H3141B11 | Target gene | 2.968 | −3.927 | |
Interferon receptor* | Ifnar | H3118F09 | Inhibitor of NF-κB | 4.5 | −3.054 | |
Lymphocyte antigen complex* | Ly6e | H3027D05 | Inducer of NF-κB | 4.029 | −2.613 | |
Metastasis | ||||||
Integrin α 3*† | Itga3 | H3137A03 | Inducer of NF-κB | 15.597 | −3.917 | |
Laminin α 5*† | Lama5 | H3002G01 | Target gene | 2.272 | −2.967 | |
Laminin receptor 1 | Lamr1 | H3075G08 | 2.169 | −1.619 | ||
Plasminogen activator, tissue | Plat | H3080H11 | Target gene | 2.667 | −2.487 | |
Procollagen type 5 α 2 | Col5a2 | H3156E09 | Target gene | 5.103 | −2.094 | |
Syndecan 1* | Sdc1 | H3013F05 | Target gene | 2.948 | −2.034 | |
Metabolism | ||||||
ATPase H+ transport*† | Atp6b | H3120H04 | Inhibitor of NF-κB | 2.247 | −2.858 | |
Branched chain ketoacid dehyd* | Bckdk | H3136B09 | 2.455 | −3.042 | ||
Choline kinase*† | Chk | H3088E07 | Inducer of NF-κB | 6.662 | −3.252 | |
Cytochrome p450* | Cyp1b1 | J0216F07 | Target gene | 22.289 | −4.286 | |
Glutathione-S-transferase* | Gstm1 | H3133A06 | Target gene | 3.037 | −3.061 | |
Low density lipoprotein receptor* | Ldlr | H3014C04 | Target gene | 2.689 | −3.226 | |
Mannose-6-phosphate receptor† | M6pr | H3092C05 | Inhibitor of NF-κB | 6.303 | −3.612 | |
Potassium intermediate* | Kcnn4 | H3054H04 | 2.778 | −2.197 | ||
Solute carrier family 12*† | Slc12a2 | H3077B02 | 2.551 | −2.145 | ||
Stress response | ||||||
Heat shock protein, 70 kDa* | Hspa5 | H3032A08 | Activates NF-κB | 14.303 | −6.369 | |
Heat shock protein 84 kDa* | Hsp84 | H3042G07 | Activates NF-κB | 3.437 | −7.198 | |
Heat shock protein 86 kDa* | Hsp86 | H3023G01 | Activates NF-κB | 2.61 | −2.34 | |
Heat shock protein cognate 70* | Hsc70 | H3133H01 | Binds NF-κB | 3.42 | −10.229 | |
Superoxide dismutase* | Sod1 | H3130B11 | Target gene | 4.784 | −2.145 | |
Signal transduction | ||||||
AXL receptortyrosine kinase*† | Axl | H3152F05 | Inhibitor of NF-κB | 2.459 | 0.938 | |
CD97 (EGF-TM7)*† | Cd97 | H3032G06 | 2.283 | −1.352 | ||
Interleukin-1 receptor associated* | Il1rak | H3042E08 | Activates NF-κB | 1.999 | −1.296 | |
Frizzled 7 homolog | Fzd7 | H3031A03 | 2.717 | −0.843 | ||
Growth arrest & DNA damage specific* | Gadd45g | H3054C02 | Activates NF-κB | 3.144 | −1.407 | |
Growth factor receptor bound* | Grb2 | H3153D02 | Activates NF-κB | 2.483 | −2.341 | |
N-myc downstream regulated* | Ndr2 | G0110H06 | Inhibits p50 | 2.248 | −2.039 | |
P13 kinase regulatory* | Pik3r1 | H3067B08 | Activates NF-κB | 4.206 | −3.539 | |
Protein tyrosine phosphatase*† | Ptpn13 | H3118G02 | Inhibitor of NF-κB | 2.844 | −9.071 | |
Ras p21 protein activator 3*† | Rasa3 | H3054E01 | Activates NF-κB | 3.223 | −2.71 | |
Ras-related C3* | Rac1 | IMAGE:477981 | 2.042 | −3.875 | ||
Transferrin receptor* | Trfr | H3059G03 | 2.216 | −1.145 | ||
Nuclear proteins/transcription factors | ||||||
Activating transcription factor† | Atf2 | J0221F08 | 1.606 | −2.696 | ||
Breast cancer, early onset† | Brca2 | H3069F08 | 2.216 | −0.604 | ||
Butyrate response factor* | Brf2 | H3015E08 | 2.072 | −2.008 | ||
High mobility group AT* | Hmga1 | H3029B11 | Target gene | 2.816 | −2.591 | |
Jerky* | Jrk | H3119F06 | 2.849 | −3.329 | ||
Myelocytomatosis oncogene* | Myc | H3089H11 | Target gene | 2.224 | −2.42 | |
Nuclear factor κB p105* | Nfkb1 | H3072E09 | 2.919 | −1.443 | ||
Sex comb on midleg-like 1† | Scml1 | H3113B01 | 2.355 | −1.154 | ||
Yes-associated protein 65 kDa | Yap | H3089H07 | 2.072 | −1.746 | ||
RNA processing | ||||||
DEAD box protein 3* | Ddx3 | H3018F11 | 2.976 | −2.055 | ||
DJ-1 protein† | DJ-1 | H3150D06 | 3.155 | −4.611 | ||
FGF inducible 14 | Fin14 | H3018G01 | 2.358 | −3.355 | ||
Nuclear ribonuclease | Hnrpa1 | H3111H11 | 4.926 | −2.785 | ||
RNA polymerase 1-1* | Rpo1-1 | H3049D09 | 2.703 | −2.328 | ||
Protein synthesis/modification | ||||||
ERO1 like*† | Ero1l | H3126B01 | 2.529 | −2.456 | ||
Ribosomal protein L27a | Rpl27a | H3009B05 | 2.183 | 1.369 |
Function Gene . | Symbol . | Clone ID . | NF-κB Association . | Fold change . | . | |
---|---|---|---|---|---|---|
. | . | . | . | LY-2/Ker . | LY-2/IkB-aM . | |
Cell cycle/growth | ||||||
Cyclin D1* | Ccnd1 | H3084D05 | Target gene | 3.351 | −2.266 | |
Cyclin D2* | Ccnd2 | H3152D01 | Target gene | 2.957 | −2.05 | |
Growth arrest specific 5* | Gas5 | H3113A12 | 6.304 | −7.813 | ||
Milk fat globule-EGF factor 8* | Mfge8 | H3126F11 | Target gene | 2.594 | −3.525 | |
Protein phosphatase 3*† | Ppp3cb | H3065C08 | Inhibitor of NF-κB | 3.117 | −2.231 | |
Proliferating cell nuclear antigen* | Pcna | H3021F12 | Target gene | 5.775 | −2.811 | |
Apoptosis | ||||||
Baculoviral IAP repeat* | Birc2 | H3074A02 | Target gene | 9.154 | −6.013 | |
Bcl-2 related ovarian killer*† | Bok1 | H3081D02 | 1.994 | −3.461 | ||
Immediate early response 3* | Ier3 | H3057B07 | Target gene | 2.865 | −3.851 | |
Transformation related protein*† | Trp53 | H3142D07 | Target gene | 2.9 | −4.142 | |
Uchrp* | Uchrp | IMAGE:605056 | 2.188 | −4.353 | ||
Inflammation/angiogenesis | ||||||
Colony stimulating factor 1* | Csf1 | H3057D05 | Target gene | 14.639 | −5.574 | |
Complement component 3*† | C3 | H3054A08 | Target gene | 5.145 | −8.303 | |
FGF receptor* | Fgfr4 | IMAGE:406823 | Target gene | 1.982 | −1.991 | |
Gro 1 oncogene* | Gro1 | H3051F10 | Target gene | 12.394 | −4.094 | |
Histocompatibility 2-L* | H2-L | H3096A12 | Target gene | 2.342 | −3.431 | |
Histocompatibility 2-D* | H2-D | H3141B11 | Target gene | 2.968 | −3.927 | |
Interferon receptor* | Ifnar | H3118F09 | Inhibitor of NF-κB | 4.5 | −3.054 | |
Lymphocyte antigen complex* | Ly6e | H3027D05 | Inducer of NF-κB | 4.029 | −2.613 | |
Metastasis | ||||||
Integrin α 3*† | Itga3 | H3137A03 | Inducer of NF-κB | 15.597 | −3.917 | |
Laminin α 5*† | Lama5 | H3002G01 | Target gene | 2.272 | −2.967 | |
Laminin receptor 1 | Lamr1 | H3075G08 | 2.169 | −1.619 | ||
Plasminogen activator, tissue | Plat | H3080H11 | Target gene | 2.667 | −2.487 | |
Procollagen type 5 α 2 | Col5a2 | H3156E09 | Target gene | 5.103 | −2.094 | |
Syndecan 1* | Sdc1 | H3013F05 | Target gene | 2.948 | −2.034 | |
Metabolism | ||||||
ATPase H+ transport*† | Atp6b | H3120H04 | Inhibitor of NF-κB | 2.247 | −2.858 | |
Branched chain ketoacid dehyd* | Bckdk | H3136B09 | 2.455 | −3.042 | ||
Choline kinase*† | Chk | H3088E07 | Inducer of NF-κB | 6.662 | −3.252 | |
Cytochrome p450* | Cyp1b1 | J0216F07 | Target gene | 22.289 | −4.286 | |
Glutathione-S-transferase* | Gstm1 | H3133A06 | Target gene | 3.037 | −3.061 | |
Low density lipoprotein receptor* | Ldlr | H3014C04 | Target gene | 2.689 | −3.226 | |
Mannose-6-phosphate receptor† | M6pr | H3092C05 | Inhibitor of NF-κB | 6.303 | −3.612 | |
Potassium intermediate* | Kcnn4 | H3054H04 | 2.778 | −2.197 | ||
Solute carrier family 12*† | Slc12a2 | H3077B02 | 2.551 | −2.145 | ||
Stress response | ||||||
Heat shock protein, 70 kDa* | Hspa5 | H3032A08 | Activates NF-κB | 14.303 | −6.369 | |
Heat shock protein 84 kDa* | Hsp84 | H3042G07 | Activates NF-κB | 3.437 | −7.198 | |
Heat shock protein 86 kDa* | Hsp86 | H3023G01 | Activates NF-κB | 2.61 | −2.34 | |
Heat shock protein cognate 70* | Hsc70 | H3133H01 | Binds NF-κB | 3.42 | −10.229 | |
Superoxide dismutase* | Sod1 | H3130B11 | Target gene | 4.784 | −2.145 | |
Signal transduction | ||||||
AXL receptortyrosine kinase*† | Axl | H3152F05 | Inhibitor of NF-κB | 2.459 | 0.938 | |
CD97 (EGF-TM7)*† | Cd97 | H3032G06 | 2.283 | −1.352 | ||
Interleukin-1 receptor associated* | Il1rak | H3042E08 | Activates NF-κB | 1.999 | −1.296 | |
Frizzled 7 homolog | Fzd7 | H3031A03 | 2.717 | −0.843 | ||
Growth arrest & DNA damage specific* | Gadd45g | H3054C02 | Activates NF-κB | 3.144 | −1.407 | |
Growth factor receptor bound* | Grb2 | H3153D02 | Activates NF-κB | 2.483 | −2.341 | |
N-myc downstream regulated* | Ndr2 | G0110H06 | Inhibits p50 | 2.248 | −2.039 | |
P13 kinase regulatory* | Pik3r1 | H3067B08 | Activates NF-κB | 4.206 | −3.539 | |
Protein tyrosine phosphatase*† | Ptpn13 | H3118G02 | Inhibitor of NF-κB | 2.844 | −9.071 | |
Ras p21 protein activator 3*† | Rasa3 | H3054E01 | Activates NF-κB | 3.223 | −2.71 | |
Ras-related C3* | Rac1 | IMAGE:477981 | 2.042 | −3.875 | ||
Transferrin receptor* | Trfr | H3059G03 | 2.216 | −1.145 | ||
Nuclear proteins/transcription factors | ||||||
Activating transcription factor† | Atf2 | J0221F08 | 1.606 | −2.696 | ||
Breast cancer, early onset† | Brca2 | H3069F08 | 2.216 | −0.604 | ||
Butyrate response factor* | Brf2 | H3015E08 | 2.072 | −2.008 | ||
High mobility group AT* | Hmga1 | H3029B11 | Target gene | 2.816 | −2.591 | |
Jerky* | Jrk | H3119F06 | 2.849 | −3.329 | ||
Myelocytomatosis oncogene* | Myc | H3089H11 | Target gene | 2.224 | −2.42 | |
Nuclear factor κB p105* | Nfkb1 | H3072E09 | 2.919 | −1.443 | ||
Sex comb on midleg-like 1† | Scml1 | H3113B01 | 2.355 | −1.154 | ||
Yes-associated protein 65 kDa | Yap | H3089H07 | 2.072 | −1.746 | ||
RNA processing | ||||||
DEAD box protein 3* | Ddx3 | H3018F11 | 2.976 | −2.055 | ||
DJ-1 protein† | DJ-1 | H3150D06 | 3.155 | −4.611 | ||
FGF inducible 14 | Fin14 | H3018G01 | 2.358 | −3.355 | ||
Nuclear ribonuclease | Hnrpa1 | H3111H11 | 4.926 | −2.785 | ||
RNA polymerase 1-1* | Rpo1-1 | H3049D09 | 2.703 | −2.328 | ||
Protein synthesis/modification | ||||||
ERO1 like*† | Ero1l | H3126B01 | 2.529 | −2.456 | ||
Ribosomal protein L27a | Rpl27a | H3009B05 | 2.183 | 1.369 |
Continued
Function Gene . | Symbol . | Clone ID . | NF-κB Association . | Fold change . | . | |
---|---|---|---|---|---|---|
. | . | . | . | LY-2/Ker . | LY-2/IkB-aM . | |
Ribosomal protein L8 | Rpl8 | H3141F09 | 2.778 | 1.005 | ||
Ribosomal protein S18* | Rps18 | H3006C11 | 2.487 | −2.424 | ||
Ubiquitin activating enzyme E1 | Ube1x | H3022E03 | Phosphorylates κB | 5.313 | −3.139 | |
Ubiquitin B | Ubb | H3138A08 | Labels κB | 8.144 | −1.171 | |
Ubiquitin conjugating enzyme E2 | Ube2h | H3057B09 | Phosphorylates κB | 3.333 | −1.199 | |
Ubiquitin conjugating enzyme E3† | Ube3a | H3102B01 | Phosphorylates κB | 4.878 | −5.096 | |
Ubiquitin specific protease 9† | Usp9x | H3139F12 | 3.769 | −3.175 | ||
Structural proteins | ||||||
Alpha tropomyosin* | Tpm1 | H3120G06 | Binds p65 | 2.421 | −4.36 | |
Cadherin* | Cdh3 | H3018F05 | Inflammatory | 2.328 | −2.706 | |
Capping protein α 2 | Cappa2 | H3085F12 | 14.293 | −7.458 | ||
Dystroglycan 1* | Dag1 | H3008B05 | Activates NF-κB | 2.593 | −4.738 | |
Epithelial protein lost*† | Eplin | H3153C05 | Activates NF-κB | 2.066 | −2.971 | |
Fascin homolog 1* | Fscn1 | H3006D08 | 2.315 | −2.581 | ||
Four and a half LIM domains* | Fhl2 | H3033C07 | 2.169 | −1.189 | ||
Keratin complex 1 acidic* | Krt1-18 | H3021B02 | Target gene | 3.105 | −5.517 | |
Keratin complex 2 basic* | Krt2-8 | H3031C01 | 2.094 | −5.568 | ||
PDZ and LIM domain 1* | Pdlim1 | J0824B03 | 5.7 | −3.775 | ||
Protocadherin 7*† | Pcdh7 | H3067F12 | Inflammatory | 6.556 | −1.026 | |
Thymopoietin* | Tmpo | H3096B08 | 9.939 | −8.153 | ||
Other | ||||||
Globin inducing factor† | Gbif | H3053F12 | 2.003 | 1.002 | ||
Metallothionein 2 | Mt2 | H3013D11 | Inhibits IκB degradation | 2.145 | −3.029 | |
Next to the Brca1*† | Nbr1 | H3061D04 | 2.367 | −1.888 | ||
RAN binding protein* | Ranbp9 | H3013A10 | Accumulates IκBα | 2.87 | −3.189 | |
Repeat family 3 gene* | Llrep3 | H3107F07 | 3.556 | −7.704 | ||
Ring finger protein 19* | Rnf19 | H3153A08 | Activates NF-κB | 2.148 | −4.402 | |
Sema domain, immunoglobin*† | Sema3f | H3134D09 | 2.191 | −1.667 | ||
Suppressor of Lec15† | Supl15h | H3090D12 | 2.001 | −1.383 | ||
TGF β inducible transcript* | Tgfb1i1 | H3122H01 | 3.068 | −2.974 |
Function Gene . | Symbol . | Clone ID . | NF-κB Association . | Fold change . | . | |
---|---|---|---|---|---|---|
. | . | . | . | LY-2/Ker . | LY-2/IkB-aM . | |
Ribosomal protein L8 | Rpl8 | H3141F09 | 2.778 | 1.005 | ||
Ribosomal protein S18* | Rps18 | H3006C11 | 2.487 | −2.424 | ||
Ubiquitin activating enzyme E1 | Ube1x | H3022E03 | Phosphorylates κB | 5.313 | −3.139 | |
Ubiquitin B | Ubb | H3138A08 | Labels κB | 8.144 | −1.171 | |
Ubiquitin conjugating enzyme E2 | Ube2h | H3057B09 | Phosphorylates κB | 3.333 | −1.199 | |
Ubiquitin conjugating enzyme E3† | Ube3a | H3102B01 | Phosphorylates κB | 4.878 | −5.096 | |
Ubiquitin specific protease 9† | Usp9x | H3139F12 | 3.769 | −3.175 | ||
Structural proteins | ||||||
Alpha tropomyosin* | Tpm1 | H3120G06 | Binds p65 | 2.421 | −4.36 | |
Cadherin* | Cdh3 | H3018F05 | Inflammatory | 2.328 | −2.706 | |
Capping protein α 2 | Cappa2 | H3085F12 | 14.293 | −7.458 | ||
Dystroglycan 1* | Dag1 | H3008B05 | Activates NF-κB | 2.593 | −4.738 | |
Epithelial protein lost*† | Eplin | H3153C05 | Activates NF-κB | 2.066 | −2.971 | |
Fascin homolog 1* | Fscn1 | H3006D08 | 2.315 | −2.581 | ||
Four and a half LIM domains* | Fhl2 | H3033C07 | 2.169 | −1.189 | ||
Keratin complex 1 acidic* | Krt1-18 | H3021B02 | Target gene | 3.105 | −5.517 | |
Keratin complex 2 basic* | Krt2-8 | H3031C01 | 2.094 | −5.568 | ||
PDZ and LIM domain 1* | Pdlim1 | J0824B03 | 5.7 | −3.775 | ||
Protocadherin 7*† | Pcdh7 | H3067F12 | Inflammatory | 6.556 | −1.026 | |
Thymopoietin* | Tmpo | H3096B08 | 9.939 | −8.153 | ||
Other | ||||||
Globin inducing factor† | Gbif | H3053F12 | 2.003 | 1.002 | ||
Metallothionein 2 | Mt2 | H3013D11 | Inhibits IκB degradation | 2.145 | −3.029 | |
Next to the Brca1*† | Nbr1 | H3061D04 | 2.367 | −1.888 | ||
RAN binding protein* | Ranbp9 | H3013A10 | Accumulates IκBα | 2.87 | −3.189 | |
Repeat family 3 gene* | Llrep3 | H3107F07 | 3.556 | −7.704 | ||
Ring finger protein 19* | Rnf19 | H3153A08 | Activates NF-κB | 2.148 | −4.402 | |
Sema domain, immunoglobin*† | Sema3f | H3134D09 | 2.191 | −1.667 | ||
Suppressor of Lec15† | Supl15h | H3090D12 | 2.001 | −1.383 | ||
TGF β inducible transcript* | Tgfb1i1 | H3122H01 | 3.068 | −2.974 |
NOTE. Total number of genes regulated by NF-κB = 105/167. Total number of genes previously associated with NF-κB = 67/167.
Genes containing κB site in promoter region.
Genes containing ACTACAG motif in coding sequence.
Selected list of genes decreased with tumor progression
Function Gene . | Symbol . | Clone ID . | NF-κB association . | Fold change . | . | |
---|---|---|---|---|---|---|
. | . | . | . | LY2/Ker . | LY2/IkB-aM . | |
Cell cycle/growth | ||||||
C-src tyrosine kinase* | Csk | L0237H04 | −2.693 | 2.358 | ||
Calmodulin | Calm | H3006H05 | Activates NF-κB via IKK | −2.554 | 2.42 | |
Cell division cycle homolog 25a | Cdc25a | H3050E04 | −2.341 | 2.269 | ||
Cell division cycle homolog 45 | Cdc45l | H3003E07 | −2.032 | 2.029 | ||
Cyclin C | Ccnc | C0117F09 | −2.739 | 2.418 | ||
Cyclin E2* | Ccne2 | C0186A01 | −2.309 | 2.155 | ||
Cyclin dependent kinase 4 | Cdk4 | H3147D06 | Target gene of NF-κB | −2.734 | 2.05 | |
Cyclin dependent kinase inhibit* | Cdkn1c | H3097D03 | −5.208 | 2.913 | ||
Platelet derived growth factor* | Pdgfa | H3146C02 | −2.15 | 2.906 | ||
Apoptosis | ||||||
ATP binding cassette* | Abcd3 | H3143E03 | NF-κB site in promoter | −2.89 | 2.535 | |
Bcl2/adenovirus E1B | Bnip3 | H3103B07 | Transient inhibitor of NF-κB | −2.364 | 2.436 | |
Fas associating w/death domain | Fadd | H3095D08 | Inducer of NF-κB | −3.597 | 2.975 | |
Inflammation/angiogenesis | ||||||
Coagulation factor III*† | F3 | H3014G02 | Activates NF-κB via IKK | −4.672 | 3.858 | |
Interleukin 17 receptor | Il17r | H3008A03 | Activates NF-κB via MAPK | −3.021 | 3.048 | |
Interleukin 2 receptor | Il2ra | J0052C08 | NF-κB site in promoter | −2.262 | 2.207 | |
Lymphocyte antigen 6 complex | Ly6 | H3115A08 | Inducer of NF-κB | −5.617 | 3.311 | |
Prothymosin β | Ptmb4 | H3143A02 | −21.739 | 8.858 | ||
Metastasis | ||||||
A disintegrin/MMP | Adamts1 | H3034B07 | −2.695 | 2.736 | ||
Cadherin 1* | Cdh1 | H3076B06 | Associated with inflammation | −2.597 | 2.313 | |
Kangai 1† | Kai1 | H3154D02 | Target gene of NF-κB | −2.816 | 2.139 | |
Lipocalin 2 | Lcn2 | H3083G02 | Associated with inflammation | −2.506 | 11.235 | |
Procollagen type 1 α | Col1a2 | H3125D01 | −4.901 | 2.886 | ||
Procollagen type II α | Col2a1 | H3026G09 | −6.896 | 2.139 | ||
Procollagen type III α | Col3a1 | H3005D11 | Inducer of NF-κB | −3.205 | 4.268 | |
Secreted acidic C-rich | Sparc | H3026D08 | −8.928 | 2.872 | ||
Tissue inhibitor of MMPs | Timp3 | H3031E01 | Two NF-κB sites in promoter | −3.3 | 3.289 | |
Metabolism | ||||||
ATPase, type 11A† | Atp11a | H3097B05 | −2.888 | 2.734 | ||
ATP synthase H+ transport | Atp5j2 | H3118C01 | Inhibitor of NF-κB | −2.191 | 2.111 | |
Glutathione peroxidase* | Gpx3 | J0088G08 | Inhibitor of NF-κB upregulates IkBa normal half-life | −2.604 | 4.065 | |
Lipopolysaccharide binding*† | Lbp | H3086G08 | Activates NF-κB via MAPK | −2.977 | 2.103 | |
Phosphoprotein enriched† | Pea15 | H3014G07 | Inducer of NF-κB | −2.424 | 1.159 | |
Pyruvate dehydrogenase*† | Pdha1 | H3068G07 | NF-κB site in promoter | −3.021 | 1.643 | |
Sterol carrier protein 2*† | Scp2 | H3122F12 | −2.412 | 1.488 | ||
Stress response | ||||||
Crystallin α 2 | Crya2 | H3143B04 | Inhibitor NF-κB | −3.921 | 3.479 | |
Signal transduction | ||||||
Adenylate kinase† | Ak2 | H3052D11 | −3.755 | 3.546 | ||
Max dimerization protein 4*† | Mad4 | H3131B07 | −2.008 | 2.131 | ||
MAD homolog 4 | Madh4 | H3128C04 | −2.765 | 2.114 | ||
NF-κB enhancer inhibitor* | Nfkbia | H3026A08 | −1.433 | 4.611 | ||
NIK-related kinase | Nrk | H3008B02 | Activates NF-κB | −2.244 | 4.859 | |
Phosphoglycerate kinase* | Pgk1 | H3023D06 | −2.659 | 2.061 | ||
Protein tyrosine phosphatase 4 | Ptp4a2 | H3088F03 | −2.118 | 1.615 | ||
Rho-associated coiled-coil | Rock1 | H3069C09 | −2.808 | 3.183 | ||
TNF receptor associated factor | Traf1 | H3015E06 | NF-κB dependent | −2.011 | 1.243 | |
Nuclear proteins/transcription factors | ||||||
Cbp/p300 interacting transactivation | Cited4 | H3076H08 | NF-κB co-activator | −2.178 | 2.745 | |
High mobility group box 1 | Hmgb1 | H3126A05 | Binds p50 subunit | −3.104 | 1.739 | |
Jun oncogene | Jun | H3058C09 | NF-κB co-activator | −2.906 | 2.057 | |
Ras-related C3 | Rac1 | H3018C09 | Inducer of NF-κB | −2.004 | 3.329 | |
RNA processing | ||||||
Nuclear protein 220† | Np220 | H3029A07 | −2.259 | 1.827 | ||
RNA polymerase II* | Rpo2-3 | H3055H08 | Coactivator of p65 | −2.639 | 4.501 | |
Protein synthesis/modification | ||||||
Eukaryotic translation 4g2 | Eif4g2 | H3113E10 | −4.698 | 2.222 | ||
Nedd4 WW-binding protein 4* | N4wbp4 | H3062G06 | −6.966 | 2.814 | ||
Structural proteins | ||||||
Alpha 2 glycoprotein 1*† | Azgp1 | IMAGE:521249 | −2.013 | 1.398 | ||
Beta spectrin 2*† | Spnb2 | H3010G09 | −3.781 | 1.015 | ||
Catenin beta* | Catnb | H3031E05 | Regulated by IKK | −3.998 | 3.061 | |
Fibronectin† | Fn1 | H3116A10 | NF-κB site in promoter | −6.201 | 4.723 | |
Catenin α 1*† | Catna1 | H3018E08 | −1.996 | 1.723 | ||
Tenascin C | Tnc | L0062E01 | NF-κB site in promoter | −2.557 | 1.956 | |
Other | ||||||
Deleted in polyposis | Dp1 | J0420H06 | −2.473 | 2.137 | ||
Insulin-like growth factor r2 | Igfr2 | H3148G08 | −2.765 | 2.494 | ||
Ninjurin 1* | Ninj1 | H3072B10 | −2.579 | 4.878 | ||
Rabaptin 5*† | Rab5ep | H3002C01 | −2.739 | 1.333 | ||
Topoisomerase II α*† | Top2a | H3139A05 | Inducer of NF-κB | −2.427 | 2.893 | |
Tumor differentially expressed† | Tde11 | H3014H10 | −2.593 | 1.18 | ||
WW domain binding 5* | Wbp5 | H3127H02 | −2.087 | 3.313 | ||
Zinc finger protein 68*† | Zfp68 | H3058F07 | −4.122 | 5.885 |
Function Gene . | Symbol . | Clone ID . | NF-κB association . | Fold change . | . | |
---|---|---|---|---|---|---|
. | . | . | . | LY2/Ker . | LY2/IkB-aM . | |
Cell cycle/growth | ||||||
C-src tyrosine kinase* | Csk | L0237H04 | −2.693 | 2.358 | ||
Calmodulin | Calm | H3006H05 | Activates NF-κB via IKK | −2.554 | 2.42 | |
Cell division cycle homolog 25a | Cdc25a | H3050E04 | −2.341 | 2.269 | ||
Cell division cycle homolog 45 | Cdc45l | H3003E07 | −2.032 | 2.029 | ||
Cyclin C | Ccnc | C0117F09 | −2.739 | 2.418 | ||
Cyclin E2* | Ccne2 | C0186A01 | −2.309 | 2.155 | ||
Cyclin dependent kinase 4 | Cdk4 | H3147D06 | Target gene of NF-κB | −2.734 | 2.05 | |
Cyclin dependent kinase inhibit* | Cdkn1c | H3097D03 | −5.208 | 2.913 | ||
Platelet derived growth factor* | Pdgfa | H3146C02 | −2.15 | 2.906 | ||
Apoptosis | ||||||
ATP binding cassette* | Abcd3 | H3143E03 | NF-κB site in promoter | −2.89 | 2.535 | |
Bcl2/adenovirus E1B | Bnip3 | H3103B07 | Transient inhibitor of NF-κB | −2.364 | 2.436 | |
Fas associating w/death domain | Fadd | H3095D08 | Inducer of NF-κB | −3.597 | 2.975 | |
Inflammation/angiogenesis | ||||||
Coagulation factor III*† | F3 | H3014G02 | Activates NF-κB via IKK | −4.672 | 3.858 | |
Interleukin 17 receptor | Il17r | H3008A03 | Activates NF-κB via MAPK | −3.021 | 3.048 | |
Interleukin 2 receptor | Il2ra | J0052C08 | NF-κB site in promoter | −2.262 | 2.207 | |
Lymphocyte antigen 6 complex | Ly6 | H3115A08 | Inducer of NF-κB | −5.617 | 3.311 | |
Prothymosin β | Ptmb4 | H3143A02 | −21.739 | 8.858 | ||
Metastasis | ||||||
A disintegrin/MMP | Adamts1 | H3034B07 | −2.695 | 2.736 | ||
Cadherin 1* | Cdh1 | H3076B06 | Associated with inflammation | −2.597 | 2.313 | |
Kangai 1† | Kai1 | H3154D02 | Target gene of NF-κB | −2.816 | 2.139 | |
Lipocalin 2 | Lcn2 | H3083G02 | Associated with inflammation | −2.506 | 11.235 | |
Procollagen type 1 α | Col1a2 | H3125D01 | −4.901 | 2.886 | ||
Procollagen type II α | Col2a1 | H3026G09 | −6.896 | 2.139 | ||
Procollagen type III α | Col3a1 | H3005D11 | Inducer of NF-κB | −3.205 | 4.268 | |
Secreted acidic C-rich | Sparc | H3026D08 | −8.928 | 2.872 | ||
Tissue inhibitor of MMPs | Timp3 | H3031E01 | Two NF-κB sites in promoter | −3.3 | 3.289 | |
Metabolism | ||||||
ATPase, type 11A† | Atp11a | H3097B05 | −2.888 | 2.734 | ||
ATP synthase H+ transport | Atp5j2 | H3118C01 | Inhibitor of NF-κB | −2.191 | 2.111 | |
Glutathione peroxidase* | Gpx3 | J0088G08 | Inhibitor of NF-κB upregulates IkBa normal half-life | −2.604 | 4.065 | |
Lipopolysaccharide binding*† | Lbp | H3086G08 | Activates NF-κB via MAPK | −2.977 | 2.103 | |
Phosphoprotein enriched† | Pea15 | H3014G07 | Inducer of NF-κB | −2.424 | 1.159 | |
Pyruvate dehydrogenase*† | Pdha1 | H3068G07 | NF-κB site in promoter | −3.021 | 1.643 | |
Sterol carrier protein 2*† | Scp2 | H3122F12 | −2.412 | 1.488 | ||
Stress response | ||||||
Crystallin α 2 | Crya2 | H3143B04 | Inhibitor NF-κB | −3.921 | 3.479 | |
Signal transduction | ||||||
Adenylate kinase† | Ak2 | H3052D11 | −3.755 | 3.546 | ||
Max dimerization protein 4*† | Mad4 | H3131B07 | −2.008 | 2.131 | ||
MAD homolog 4 | Madh4 | H3128C04 | −2.765 | 2.114 | ||
NF-κB enhancer inhibitor* | Nfkbia | H3026A08 | −1.433 | 4.611 | ||
NIK-related kinase | Nrk | H3008B02 | Activates NF-κB | −2.244 | 4.859 | |
Phosphoglycerate kinase* | Pgk1 | H3023D06 | −2.659 | 2.061 | ||
Protein tyrosine phosphatase 4 | Ptp4a2 | H3088F03 | −2.118 | 1.615 | ||
Rho-associated coiled-coil | Rock1 | H3069C09 | −2.808 | 3.183 | ||
TNF receptor associated factor | Traf1 | H3015E06 | NF-κB dependent | −2.011 | 1.243 | |
Nuclear proteins/transcription factors | ||||||
Cbp/p300 interacting transactivation | Cited4 | H3076H08 | NF-κB co-activator | −2.178 | 2.745 | |
High mobility group box 1 | Hmgb1 | H3126A05 | Binds p50 subunit | −3.104 | 1.739 | |
Jun oncogene | Jun | H3058C09 | NF-κB co-activator | −2.906 | 2.057 | |
Ras-related C3 | Rac1 | H3018C09 | Inducer of NF-κB | −2.004 | 3.329 | |
RNA processing | ||||||
Nuclear protein 220† | Np220 | H3029A07 | −2.259 | 1.827 | ||
RNA polymerase II* | Rpo2-3 | H3055H08 | Coactivator of p65 | −2.639 | 4.501 | |
Protein synthesis/modification | ||||||
Eukaryotic translation 4g2 | Eif4g2 | H3113E10 | −4.698 | 2.222 | ||
Nedd4 WW-binding protein 4* | N4wbp4 | H3062G06 | −6.966 | 2.814 | ||
Structural proteins | ||||||
Alpha 2 glycoprotein 1*† | Azgp1 | IMAGE:521249 | −2.013 | 1.398 | ||
Beta spectrin 2*† | Spnb2 | H3010G09 | −3.781 | 1.015 | ||
Catenin beta* | Catnb | H3031E05 | Regulated by IKK | −3.998 | 3.061 | |
Fibronectin† | Fn1 | H3116A10 | NF-κB site in promoter | −6.201 | 4.723 | |
Catenin α 1*† | Catna1 | H3018E08 | −1.996 | 1.723 | ||
Tenascin C | Tnc | L0062E01 | NF-κB site in promoter | −2.557 | 1.956 | |
Other | ||||||
Deleted in polyposis | Dp1 | J0420H06 | −2.473 | 2.137 | ||
Insulin-like growth factor r2 | Igfr2 | H3148G08 | −2.765 | 2.494 | ||
Ninjurin 1* | Ninj1 | H3072B10 | −2.579 | 4.878 | ||
Rabaptin 5*† | Rab5ep | H3002C01 | −2.739 | 1.333 | ||
Topoisomerase II α*† | Top2a | H3139A05 | Inducer of NF-κB | −2.427 | 2.893 | |
Tumor differentially expressed† | Tde11 | H3014H10 | −2.593 | 1.18 | ||
WW domain binding 5* | Wbp5 | H3127H02 | −2.087 | 3.313 | ||
Zinc finger protein 68*† | Zfp68 | H3058F07 | −4.122 | 5.885 |
NOTE. Number of genes regulated by NF-κB = 47/141. Number of genes previously associated with NF-κB = 39/141.
Genes containing kB site in promoter region.
Genes containing ACTACAG motif in coding sequence.